Literature DB >> 17699813

Keeping science on top in drug evaluation.

Jerry Avorn1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17699813     DOI: 10.1056/NEJMp078134

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

2.  Direct to consumer advertising of drugs in Europe.

Authors:  Nicola Magrini; Maria Font
Journal:  BMJ       Date:  2007-09-15

3.  Outcome reporting among drug trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  Ann Intern Med       Date:  2010-08-03       Impact factor: 25.391

Review 4.  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.

Authors:  Sven Trelle; Stephan Reichenbach; Simon Wandel; Pius Hildebrand; Beatrice Tschannen; Peter M Villiger; Matthias Egger; Peter Jüni
Journal:  BMJ       Date:  2011-01-11

5.  Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K.

Authors:  Mi-Sung Kim; Jong-Eun Kim; Do Young Lim; Zunnan Huang; Hanyong Chen; Alyssa Langfald; Ronald A Lubet; Clinton J Grubbs; Zigang Dong; Ann M Bode
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

Review 6.  Rosiglitazone and cardiovascular risk.

Authors:  Sanjay Kaul; George A Diamond
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

7.  Ethics, economics and the regulation and adoption of new medical devices: case studies in pelvic floor surgery.

Authors:  Sue Ross; Charles Weijer; Amiram Gafni; Ariel Ducey; Carmen Thompson; Rene Lafreniere
Journal:  BMC Med Ethics       Date:  2010-08-26       Impact factor: 2.652

8.  GPs' opinions of public and industrial information regarding drugs: a cross-sectional study.

Authors:  Ingmarie Skoglund; Cecilia Björkelund; Kirsten Mehlig; Ronny Gunnarsson; Margareta Möller
Journal:  BMC Health Serv Res       Date:  2011-08-25       Impact factor: 2.655

9.  Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.

Authors:  Xiaoting Feng; Mei Tian; Wei Zhang; Hong Mei
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

Review 10.  Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice.

Authors:  Kok Yuen Ho; Kok Ann Gwee; Yew Kuang Cheng; Kam Hon Yoon; Hwan Tak Hee; Abdul Razakjr Omar
Journal:  J Pain Res       Date:  2018-09-20       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.